机构:[1]Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58203-9061, USA.[2]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan 610041, China.四川大学华西医院[3]Inflammations & Allergic Diseases Research Unit, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646004, China.[4]State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) systems in bacteria and archaea provide adaptive immunity against invading foreign nucleic acids. Previous studies suggest that certain bacteria employ their Type II CRISPR-Cas systems to target their own genes, thus evading host immunity. However, whether other CRISPR-Cas systems have similar functions during bacterial invasion of host cells remains unknown. Here we identify a novel role for Type I CRISPR-Cas systems in evading host defenses in Pseudomonas aeruginosa strain UCBPP-PA14. The Type I CRISPR-Cas system of PA14 targets the mRNA of the bacterial quorum-sensing regulator LasR to dampen the recognition by toll-like receptor 4, thus diminishing the pro-inflammatory responses of the host in cell and mouse models. Mechanistically, this nuclease-mediated RNA degradation requires a "5'-GGN-3'" recognition motif in the target mRNA, and HD and DExD/H domains in Cas3 of the Type I CRISPR-Cas system. As LasR and Type I CRISPR-Cas systems are ubiquitously present in bacteria, our findings elucidate an important common mechanism underlying bacterial virulence.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类|1 区生物
小类|1 区细胞生物学
最新[2023]版:
大类|1 区生物学
小类|1 区细胞生物学
第一作者:
第一作者机构:[1]Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58203-9061, USA.
通讯作者:
通讯机构:[1]Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58203-9061, USA.[2]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan 610041, China.
推荐引用方式(GB/T 7714):
Li Rongpeng,Fang Lizhu,Tan Shirui,et al.Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity.[J].Cell Research.2016,26(12):1273-1287.doi:10.1038/cr.2016.135.
APA:
Li Rongpeng,Fang Lizhu,Tan Shirui,Yu Min,Li Xuefeng...&Wu Min.(2016).Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity..Cell Research,26,(12)
MLA:
Li Rongpeng,et al."Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity.".Cell Research 26..12(2016):1273-1287